Celera Genomics Group-an Applera Corp. Business Registration Statement Relating to the Separation of Celera Diagnostics from Applera Corporation Declared Effective by the S.E.C.

Published: Jun 20, 2008

NORWALK, Conn.--(BUSINESS WIRE)--Applera Corporation today announced that the registration statement relating to the proposed separation of its Celera (NYSE:CRA) business has been declared effective by the SEC, with the separation expected to be completed at 12:01 a.m. EDT, on July 1, 2008, subject to satisfaction of certain conditions, including receipt of certain consents and listing of the Celera Corporation common stock on the NASDAQ Stock Market. Upon completion of the separation, Celera Corporation will hold all of the businesses, assets and liabilities attributed to the Celera Group, and will be an independent, publicly traded company whose shares are expected to be listed on the NASDAQ Stock Market when trading opens at 9:30 a.m. EDT, on July 1, 2008.

Back to news